相关实验视频
Updated: Jan 8, 2026
11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
58.4K
关于自主性障碍治疗的最新情况
Abdulmunaim M Eid1, Gabriel E Vázquez-Vélez1, Beatriz Maliszewski1
1Department of Neurology, Washington University, School of Medicine, 660 S. Euclid Ave, St. Louis, MO, USA.
Current treatment options in neurology
|December 17, 2025
概括
自主性疾病会引起像正静性低血压和胃这样的症状. 本综述涵盖了既定和新兴的治疗方法,包括神经调节器械和新药,以管理dysautonomia的表现.
科学领域:
- 神经学 神经学
- 自主神经系统研究 自主神经系统研究
- 临床治疗学 临床治疗学
背景情况:
- 自主性障碍,或dysautonomia,扰乱身体的平衡,导致各种症状.
- 导致dysautonomia的原因各不相同,包括神经退行,自身免疫和药物副作用.
- 虽然改变疾病的治疗方法对于常见原因是有限的,但症状管理至关重要.
研究的目的:
- 审查已建立和最近的治疗策略来管理dysautonomia.
- 提供一种临床方案来处理自主性障碍的管理.
- 为了突出新型神经调节器和药理学药剂.
主要方法:
- 对 dysautonomia 的既定和新兴治疗策略的审查.
- 专注于常见的临床问题和逐步管理方法.
- 非药物,药物和神经调节治疗的整合.
主要成果:
- 神经调节器件在正静性低血压,尿路功能障碍,性功能障碍,便秘和胃方面表现有前途.
- 较新的药物,如德洛克西多巴,β-3上腺体激动剂,普鲁卡洛普里德,伊格利希巴特和林纳克洛提德,提供了更好的疗效和耐受性.
- 整合多种策略的逐步方法有助于管理常见的dysautonomia症状.
结论:
- 有效的dysautonomia管理依赖于治疗策略的组合.
- 新兴的神经调节和药理选择扩大了治疗的可能性.
- 结构化的临床方法对于优化自主性疾病患者护理至关重要.
相关概念视频
01:18Disorders of the Autonomic Nervous System
1.4K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.4K
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.6K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.6K
01:22Autonomic Nervous System
11.9K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
11.9K
01:24Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:26Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K